Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report)'s stock price shot up 5.7% during mid-day trading on Tuesday . The company traded as high as $3.28 and last traded at $3.06. 4,058,369 shares were traded during mid-day trading, a decline of 43% from the average session volume of 7,113,428 shares. The stock had previously closed at $2.89.
Clover Health Investments Price Performance
The business's 50 day moving average price is $3.12 and its 200-day moving average price is $3.58. The company has a market cap of $1.62 billion, a P/E ratio of -64.10 and a beta of 1.86.
Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.12. Clover Health Investments had a negative net margin of 1.69% and a negative return on equity of 7.42%. The company had revenue of $462.33 million during the quarter, compared to analysts' expectations of $466.93 million. As a group, research analysts forecast that Clover Health Investments, Corp. will post -0.12 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the stock. Swiss National Bank raised its stake in Clover Health Investments by 6.3% during the 4th quarter. Swiss National Bank now owns 802,100 shares of the company's stock worth $2,527,000 after buying an additional 47,700 shares during the period. Counterpoint Mutual Funds LLC grew its holdings in Clover Health Investments by 153.0% during the fourth quarter. Counterpoint Mutual Funds LLC now owns 233,392 shares of the company's stock worth $735,000 after purchasing an additional 141,148 shares during the period. Graham Capital Management L.P. acquired a new stake in Clover Health Investments during the fourth quarter worth approximately $889,000. Marshall Wace LLP raised its position in shares of Clover Health Investments by 167.6% in the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company's stock valued at $11,875,000 after buying an additional 2,360,902 shares in the last quarter. Finally, Barclays PLC raised its position in shares of Clover Health Investments by 336.5% in the fourth quarter. Barclays PLC now owns 461,692 shares of the company's stock valued at $1,454,000 after buying an additional 355,926 shares in the last quarter. Institutional investors own 19.77% of the company's stock.
Clover Health Investments Company Profile
(
Get Free Report)
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Featured Stories
Before you consider Clover Health Investments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.
While Clover Health Investments currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
